Oncotarget

Research Papers:

Kanglaite inhibits EMT caused by TNF-α via NF-κΒ inhibition in colorectal cancer cells

Guiling Shi, Xiaoli Zheng, Shiwu Zhang, Xiaojing Wu, Fei Yu, Yijia Wang _ and Fei Xing

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:6771-6779. https://doi.org/10.18632/oncotarget.23645

Metrics: PDF 935 views  |   HTML 1709 views  |   ?  


Abstract

Guiling Shi1,*, Xiaoli Zheng1,*, Shiwu Zhang1, Xiaojing Wu1, Fei Yu3, Yijia Wang1 and Fei Xing2

1Tianjin Union Medical Center, Tianjin 300121, China

2The Key Laboratory of Weak Light Nonlinear Photonics, Ministry of Education, Teda Applied Physics School and School of Physics, Nankai University, Tianjin 300071, China

3School of Pharmacy, Tianjin Medical University, Tianjin 300121, China

*These authors contributed equally to this work

Correspondence to:

Yijia Wang, email: yijiawang_1980@163.com

Fei Xing, email: 370027468@qq.com

Keywords: TNF-α; EMT; kanglaite; NF-κΒ; colorectal cancer cell lines

Received: November 01, 2017     Accepted: December 01, 2017     Published: December 22, 2017

ABSTRACT

Tumor necrosis factor-alpha is a critical pro-inflammatory cytokine produced by macrophages and was once considered an anti-tumor agent. However, a low dose of tumor necrosis factor-alpha can cause epithelial mesenchymal transition, angiogenesis and metastasis. NF-κΒ contributes to epithelial mesenchymal transition induced by tumor necrosis factor-alpha. Kanglaite, an extract from the Coix lacryma-jobi (adlay) seed, is an NF-κΒ inhibitor. The aim of this study was to investigate whether Kanglaite could inhibit epithelial mesenchymal transition caused by tumor necrosis factor-alpha using four colorectal cancer cell lines, HCT106, HCT116, LoVo and CT26. Our results showed that tumor necrosis factor-alpha -mediated activation of NF-κΒ, caused changes in epithelial mesenchymal transition -related protein expression, and increased migration and invasion in all four cell lines. However, these effects were inhibited by Kanglaite when used in combination with tumor necrosis factor-alpha. In a subcutaneous tumor model of CT26, tumor necrosis factor-alpha enhanced the tumorigenic ability of the cells, and again this was inhibited by Kanglaite. However, treatment with Kanglaite alone caused almost no inhibition of epithelial mesenchymal transition -mediated tumor growth, when cells were pretreated with tumor necrosis factor-alpha prior to injection. These results suggest that Kanglaite inhibits tumor necrosis factor-alpha -mediated epithelial mesenchymal transition in colorectal cancer cell lines via inhibition of NF-κΒ.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 23645